Materials • Major Chemicals
$75.37 ▲ +1.20
(+1.62%)
MKT CAP: $2.59B • VOL: 342.5K
52W L $46 52W H $79
NGVT // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.17B | $1.20B | $1.22B |
| YoY Revenue Growth % | -2.7% | -1.3% | — |
| Gross Profit | $461.5M | $464.8M | — |
| Gross Margin % | 39.5% | 38.7% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $418.7M | $425.9M | $423.2M |
| Operating Margin % | 35.9% | 35.5% | 34.8% |
| Net Income (GAAP) | -$167.1M | -$430.3M | -$5.4M |
| EBITDA (Normalized) | — | — | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $331.2M | $128.6M | $205.1M |
| Capital Expenditures (CapEx) | — | — | — |
| Free Cash Flow (FCF) | $331.2M | $128.6M | $205.1M |
| FCF Margin % | 28.4% | 10.7% | 16.9% |
| Return on Invested Capital (ROIC %) | 95.0% | 95.0% | — |
| Cash & Short-Term Equivalents | $78.1M | $68.0M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $29.7M | $195.2M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR NGVT.